We are live on ! Find out more
CALT

Calliditas Therapeutics AB American Depositary Shares
CALT

Delisted

CALT was delisted on the 20th of September, 2024.

Back to rankings

23 hedge funds and large institutions have $76.2M invested in Calliditas Therapeutics AB American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+23
Holders Change %
–
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$14.9M
2
VC
Vivo Capital
California
+$11.5M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$8.91M
4
HA
HHLR Advisors
Cayman Islands
+$6.93M
5
LGM
Logos Global Management
California
+$5.94M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$17.5M +$14.9M +750,000 New
VC
2
Vivo Capital
California
$13.5M +$11.5M +580,000 New
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$10.4M +$8.91M +450,000 New
HA
4
HHLR Advisors
Cayman Islands
$8.15M +$6.93M +350,000 New
LGM
5
Logos Global Management
California
$6.99M +$5.94M +300,000 New
O
6
OrbiMed
New York
$5.22M +$4.46M +225,000 New
ECM
7
Endurant Capital Management
California
$3.72M +$3.17M +160,218 New
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$2.32M +$1.98M +99,873 New
Deutsche Bank
9
Deutsche Bank
Germany
$1.74M +$1.49M +75,000 New
PCM
10
Pentwater Capital Management
Florida
$1.53M +$1.31M +66,000 New
Citadel Advisors
11
Citadel Advisors
Florida
$1.48M +$1.26M +63,551 New
Millennium Management
12
Millennium Management
New York
$1.19M +$1.02M +51,265 New
Tudor Investment Corp
13
Tudor Investment Corp
Connecticut
$816K +$696K +35,152 New
CCM
14
CAAS Capital Management
New York
$580K +$495K +25,000 New
MWNA
15
Marshall Wace North America
New York
$432K +$367K +18,535 New
WMSA
16
Weiss Multi-Strategy Advisers
New York
$233K +$199K +10,023 New
Jane Street
17
Jane Street
New York
$219K +$179K +9,035 New
OMC
18
Old Mission Capital
Illinois
$203K +$173K +8,744 New
FIA
19
FNY Investment Advisers
New York
$14K +$12.4K +625 New
US Bancorp
20
US Bancorp
Minnesota
$9K +$7.92K +400 New
CSS
21
Cubist Systematic Strategies
Connecticut
$8K +$7.25K +366 New
Morgan Stanley
22
Morgan Stanley
New York
$2K +$1.37K +69 New
TRCT
23
Tower Research Capital (TRC)
New York
$1K +$1.27K +64 New

CALT Hedge Fund Activity: Q2 2020 in Review

23 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Calliditas Therapeutics AB American Depositary Shares (CALT) for Q2 2020, worth a combined $76.2M.

Buyers outnumbered sellers: 23 funds opened new CALT positions and 0 closed out — a net gain of 23 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $14.9M.

  • 23 institutional investors held Calliditas Therapeutics AB American Depositary Shares (CALT) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $76.2M of Calliditas Therapeutics AB American Depositary Shares stock for Q2 2020.
  • 23 funds opened new Calliditas Therapeutics AB American Depositary Shares positions in Q2 2020 and 0 closed out, a net change of +23 holders.
  • The largest Calliditas Therapeutics AB American Depositary Shares buyer in Q2 2020 was BVF Inc, an estimated $14.9M added.

Based on aggregated 13F filings for Q2 2020.